IJERPH | Free Full-Text | Shorter Incubation Period among Unvaccinated Delta Variant Coronavirus Disease 2019 Patients in Japan
IJMS | Free Full-Text | Syndecan-4 Is a Key Facilitator of the SARS-CoV-2 Delta Variant’s Superior Transmission
Functional expression of opioid receptors and other human GPCRs in yeast engineered to produce human sterols | Nature Communications
Bacteria-enabled oral delivery of a replicon-based mRNA vaccine candidate protects against ancestral and delta variant SARS-CoV-2: Molecular Therapy
A Universal DNA Aptamer that Recognizes Spike Proteins of Diverse SARS‐CoV‐2 Variants of Concern - Zhang - 2022 - Chemistry – A European Journal - Wiley Online Library
Frontiers | Heteromerization Modulates mu Opioid Receptor Functional Properties in vivo
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination - ScienceDirect
Interaction Analysis of the Spike Protein of Delta and Omicron Variants of SARS-CoV-2 with hACE2 and Eight Monoclonal Antibodies Using the Fragment Molecular Orbital Method | Journal of Chemical Information and Modeling
Emergence of SARS‐CoV‐2 Omicron variant and strategies for tackling the infection - Wu - 2022 - Immunity, Inflammation and Disease - Wiley Online Library
Frontiers | SARS-CoV-2 Variants, Vaccines, and Host Immunity
Deep learning guided optimization of human antibody against SARS-CoV-2 variants with broad neutralization | PNAS
Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern - eBioMedicine
Rapid assessment of SARS-CoV-2–evolved variants using virus-like particles | Science
Identification and differential usage of a host metalloproteinase entry pathway by SARS-CoV-2 Delta and Omicron - ScienceDirect
Elucidating the active δ-opioid receptor crystal structure with peptide and small-molecule agonists | Science Advances
The antigenicity of SARS-CoV-2 Delta variants aggregated 10 high-frequency mutations in RBD has not changed sufficiently to replace the current vaccine strain | Signal Transduction and Targeted Therapy
Frontiers | The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape
Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum | NEJM
Vaccines | Free Full-Text | The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far
Emerging SARS-CoV-2 variants of concern and potential intervention approaches | Critical Care | Full Text
